Page last updated: 2024-10-31

milrinone and Leukemia, Megakaryoblastic, Acute

milrinone has been researched along with Leukemia, Megakaryoblastic, Acute in 1 studies

Leukemia, Megakaryoblastic, Acute: An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zurbonsen, K1
Michel, A1
Vittet, D1
Bonnet, PA1
Chevillard, C1

Other Studies

1 other study available for milrinone and Leukemia, Megakaryoblastic, Acute

ArticleYear
Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line.
    Biochemical pharmacology, 1997, Apr-25, Volume: 53, Issue:8

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Cell Division; Cyclic AMP; Humans; Isoe

1997